| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |